284 related articles for article (PubMed ID: 11531318)
41. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.
García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E
Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429
[TBL] [Abstract][Full Text] [Related]
42. [Treatment of febrile neutropenia in patients with solid tumors].
Novotný J; Petruzelka L; Jedlicková A; Mikolásová B
Cas Lek Cesk; 1998 Nov; 137(22):694-9. PubMed ID: 9929937
[TBL] [Abstract][Full Text] [Related]
43. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
Hodgson-Viden H; Grundy PE; Robinson JL
BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
[TBL] [Abstract][Full Text] [Related]
44. [Oral antibiotics for non-Hodgkin's lymphoma patients with low risk neutropenic fever--a comparative controlled study].
Shacham-Abulafia A; Elis A; Manor Y; Lishner M
Harefuah; 2010 Jun; 149(6):344-8, 405. PubMed ID: 20941921
[TBL] [Abstract][Full Text] [Related]
45. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation.
Talcott JA; Finberg R; Mayer RJ; Goldman L
Arch Intern Med; 1988 Dec; 148(12):2561-8. PubMed ID: 3196123
[TBL] [Abstract][Full Text] [Related]
46. Risk assessment and treatment of low-risk patients with febrile neutropenia.
Kern WV
Clin Infect Dis; 2006 Feb; 42(4):533-40. PubMed ID: 16421798
[TBL] [Abstract][Full Text] [Related]
47. [Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile].
Rabagliati B R; Fuentes L G; Orellana U E; Oporto C J; Domínguez M I; Benítez G R; Aedo C I; Ramos G G; Garrido S M; García C P
Rev Chilena Infectol; 2009 Apr; 26(2):106-13. PubMed ID: 19621141
[TBL] [Abstract][Full Text] [Related]
48. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
[TBL] [Abstract][Full Text] [Related]
49. Ambulatory treatment with ceftriaxone in febrile neutropenic children.
Kaplinsky C; Drucker M; Goshen J; Tamary H; Cohen IJ; Zaizov R
Isr J Med Sci; 1994 Aug; 30(8):649-51. PubMed ID: 8045751
[TBL] [Abstract][Full Text] [Related]
50. [Infections in cancer patients with granulocytopenia. Retrospective studies of 59 febrile episodes with hospitalization].
Ghosn M; Dagher E; Nasr F; Chahine G; Taleb N; Nasnas R; Ghayad E
J Med Liban; 1994; 42(3):117-22. PubMed ID: 7629843
[TBL] [Abstract][Full Text] [Related]
51. Neutropenia and fever in patients receiving chemotherapy in a community teaching hospital: results of a retrospective chart review.
Obadina M; Cho C; Oketunji A; Waterfield W
Md Med J; 1994 Nov; 43(11):977-80. PubMed ID: 7808201
[TBL] [Abstract][Full Text] [Related]
52. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
[TBL] [Abstract][Full Text] [Related]
53. Bacterial lung sepsis in patients with febrile neutropenia.
Lanoix JP; Schmit JL; Douadi Y
Curr Opin Pulm Med; 2012 May; 18(3):175-80. PubMed ID: 22343426
[TBL] [Abstract][Full Text] [Related]
54. Bacteremia caused by the Bacteroides fragilis group in patients with hematologic diseases.
Funada H; Matsuda T
Jpn J Clin Oncol; 1995 Jun; 25(3):86-90. PubMed ID: 7596053
[TBL] [Abstract][Full Text] [Related]
55. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H
J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896
[TBL] [Abstract][Full Text] [Related]
56. Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department.
Volpe D; Harrison S; Damian F; Rachh P; Kahlon PS; Morrissey L; Mack J; Akenroye A; Stack AM
Pediatrics; 2012 Jul; 130(1):e201-10. PubMed ID: 22711718
[TBL] [Abstract][Full Text] [Related]
57. Implementation of an evidence-based order set to impact initial antibiotic time intervals in adult febrile neutropenia.
Best JT; Frith K; Anderson F; Rapp CG; Rioux L; Ciccarello C
Oncol Nurs Forum; 2011 Nov; 38(6):661-8. PubMed ID: 22037329
[TBL] [Abstract][Full Text] [Related]
58. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A
Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644
[TBL] [Abstract][Full Text] [Related]
59. Inappropriate antibiotic therapy in febrile cancer patients with bacteremia.
Spanik S; West D; Pichna P; Novotny J; Dacok J; Mraz M; Chmelik B; Krupova I; Krcmery V
Clin Perform Qual Health Care; 1998; 6(3):109-13. PubMed ID: 10182556
[TBL] [Abstract][Full Text] [Related]
60. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.
Viscoli C; Paesmans M; Sanz M; Castagnola E; Klastersky J; Martino P; Glauser M;
Clin Infect Dis; 2001 Jun; 32(11):1532-7. PubMed ID: 11340522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
